WENDY MCLAUGHLIN: Open Payments
NPI 1770538415 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 22 payments from 9 companies in 2025. Trend: 2023 $378 · 2024 $299 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $192 |
| Sequel Med Tech, LLC | 2 | $148 |
| Dexcom, Inc. | 2 | $54 |
| Amgen Inc. | 2 | $49 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $23 |
| Antares Pharma, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| CeQur Corporation | 1 | $16 |
Products named: TWIIST, Ozempic, Dexcom G6 Transmitter, TEPEZZA, RECORLEV, FREESTYLE LIBRE 3, XYOSTED, JARDIANCE.
Industry payments across VA — which companies pay providers there.
